Skip to Main Content

Reckitt Benckiser Group PLC (OTCM: RBGLY) Securities Fraud Class Action

View Complaint
COMPANY       Reckitt Benckiser Group PLC
COURT United States District Court for the Southern District of New York
CASE NUMBER 1:25-cv-04708
JUDGE The Hon. John Peter Cronan
CLASS PERIOD  January 13, 2021, through July 28, 2024
SECURITY TYPE  American Depositary Shares

LEAD PLAINTIFF DEADLINE IS AUGUST 4, 2025.

If you have suffered losses and would like to discuss your rights, please fill out this form or you may contact Jonathan Naji, Esq. at (484) 270-1453 or via e-mail at info@ktmc.com.

Case Background:
A class action lawsuit was filed on behalf of those who purchased or otherwise acquired Reckitt Benckiser Group PLC (“Reckitt”) (OTCM: RBGLY) American Depositary Shares between January 13, 2021, and July 28, 2024, inclusive (the “Class Period”).

The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material facts about the company’s business, operations, and prospects.  Specifically, Defendants misrepresented and/or failed to disclose that: (1) preterm infants were at an increased risk of developing Necrotizing Enterocolitis (“NEC”), a deadly intestinal disease, by consuming Enfamil; (2) the negative impact on Reckitt’s sales of Enfamil increased its exposure to legal claims because of the risk that premature infants could develop NEC; and (3) as a result, Defendants’ statements about the company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
 

What is a Lead Plaintiff?

A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Filling out the online form above or communicating with any counsel is not necessary to participate or share in any recovery achieved in this case.  Any member of the purported class may move the court to serve as a lead plaintiff through counsel of his/her choice, or may choose to do nothing and remain an inactive class member.

Complete this form with your transactions in Reckitt Benckiser Group PLC American Depositary Shares between January 13, 2021, and July 28, 2024.

Click Here to Print PDF of this Form

SUBMIT YOUR INFORMATION
* Denotes required field
Date
# of Shares
Price per Share
Date
Principal Amount
Amount Paid
Series or CUSIP
Date
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of Reckitt Benckiser Group PLC prior to the Class Period?
Are you a current or former employee of Reckitt Benckiser Group PLC?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC disclaimer
I would like to receive new case alerts by email